Live Breaking News & Updates on Drdo covid drug

Stay informed with the latest breaking news from Drdo covid drug on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Drdo covid drug and stay connected to the pulse of your community

DRDO invites EoI to transfer technology of COVID 2-DG drug for bulk production

According to the EoI document, applications should be submitted before June 17 through email

Hyderabad , Andhra-pradesh , India , Technical-assessment-committee , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , First-come-served-basis , Active-pharmaceutical-ingredient

Covid treatment: DRDO invites bids to transfer technology of 2-DG drug

Requirements for the bidders include a drug license to manufacture Active Pharmaceutical Ingredient (API) from Drug Licensing Authorities and WHO GMP (Good Manufacturing Practices) certification

Active-pharmaceutical-ingredient , Drug-licensing-authorities , Good-manufacturing-practices , 2dg-production , 2-dg-production , 2dg-availability , 2-dg , Covid-treatment-drug , Covid-treatment-news , Covid-treatment-list , Covid-treatment

10,000 sachets of anti-Covid drug 2-DG to be available in market from Thursday, says Rajnath Singh | India News

The anti-Covid drug has been developed by the Defence Research and Development Organisation (DRDO).
Launching the 'Services e-Health Assistance and Tele-consultation (SeHAT)' OPD Portal via video conferencing, Singh lauded the armed forces, stating that it is a key step taken at a very critical time for the health of service personnel as it will reduce the load of the hospitals.
Chief of Defence Staff Gen Bipin Rawat, Army Chief Gen M M Naravane, and Navy Chief Admiral Karambir Singh were among those who attended the event.
Referring to the second wave of the Covid-19, the Defence Minister said, "This wave of Covid is unprecedented and more dangerous than earlier. But the Defence Ministry has rendered its services in the second wave too. DRDO has set up Covid hospitals and oxygen generation plants in Delhi, Lucknow, Varanasi, and many other parts of the country."

Lucknow , Uttar-pradesh , India , Delhi , Varanasi , Rajnath-singh , G-satheesh-reddy , Karambir-singh , Genmm-naravane , Gen-bipin-rawat , Dr-reddy-lab , Health-assistance

Coronavirus | 2-DG Anti Covid Drug: DRDO launches anti-COVID medicine, 2-deoxy-D-glucose, know all about how it works

facebook
Pintrest
The DRDO's (Defence Research and Development Organisation) newly launched anti-COVID medicine, 2-deoxy-D-glucose is being hailed as an innovative holy grail for COVID patients in India right now, who are currently battling for their lives and scouring for oxygen amidst a deadly grasp of the second wave of infections.
The innovative therapeutic drug, which has been launched for use today (May 17) is also said to hasten recovery timelines. But how effective is it really? Can all COVID-19 patients take it? Here's a brief explainer on the same.
What do we know about the drug, 2-deoxy-D-glucose?
2-deoxy-D-glucose is the first-ever 'fully homegrown' anti-COVID medicine which has been developed in India. According to researchers, it is one of the first therapeutic COVID-19 drugs which works to stop viral growth in the body, reduce the need for external oxygen.

Delhi , India , Hyderabad , Andhra-pradesh , Telangana , Development-organisation , Institute-of-nuclear-medicine , Defence-research , Nuclear-medicine , Allied-sciences , Drugs-controller-general

First batch of DRDO's anti-Covid drug to be released on Monday | India News

India News: NEW DELHI: The first batch of anti-COVID drug 2-DG, developed by the DRDO, will be released on Monday by defence minister Rajnath Singh and health min.

Hyderabad , Andhra-pradesh , India , Harsh-vardhan , Rajnath-singh , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Drugs-controller-general , Nuclear-medicine , Allied-sciences , Ndia-news